Guobang Pharma Ltd. (SHA:605507)
China · Delayed Price · Currency is CNY 15.71
-0.10 (-0.63%)
Nov 6, 2026, 3:00 PM CST
Guobang Pharma Market Cap
Guobang Pharma has a market cap or net worth of 12.11 billion as of November 6, 2026. It is the 6,931st most valuable company in the world and the 1,320th biggest in China. Its market cap has decreased by 1.12% in one year.
Market Cap
12.11B
Enterprise Value
10.57B
Revenue
6.13B
Global Rank
Country Rank
#1,320 China
PE Ratio
19.49
ChartMarket Cap Chart
Since August 2, 2021, Guobang Pharma's market cap has decreased from 26.21B to 12.11B, a decrease of -53.79%. That is a compound annual growth rate of -13.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 12.11B | -11.68% |
| Dec 31, 2025 | 13.71B | 19.12% |
| Dec 31, 2024 | 11.51B | 17.32% |
| Dec 29, 2023 | 9.81B | -33.66% |
| Dec 30, 2022 | 14.79B | -8.19% |
| Dec 31, 2021 | 16.11B | -38.53% |
| Aug 2, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Henan Lingrui Pharmaceutical | 13.54B |
| ApicHope Pharmaceutical Group | 13.36B |
| Porton Pharma Solutions | 12.99B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 12.85B |
| Fujian Cosunter Pharmaceutical | 12.72B |
| Shenzhen Hepalink Pharmaceutical Group | 12.52B |
| Beijing Aosaikang Pharmaceutical | 11.75B |
| Shanghai Shyndec Pharmaceutical | 11.12B |